Brandon A Carter-Cooper

Brandon A Carter-Cooper

UNVERIFIED PROFILE

Are you Brandon A Carter-Cooper?   Register this Author

Register author
Brandon A Carter-Cooper

Brandon A Carter-Cooper

Publications by authors named "Brandon A Carter-Cooper"

Are you Brandon A Carter-Cooper?   Register this Author

9Publications

326Reads

28Profile Views

Potently inhibiting cancer cell migration with novel 3H-pyrazolo[4,3-f]quinoline boronic acid ROCK inhibitors.

Eur J Med Chem 2019 Oct 29;180:449-456. Epub 2019 Jun 29.

Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, IN, 47907, USA; Institute for Drug Discovery, Purdue University, 720 Clinic Drive, West Lafayette, IN, 47907, USA; Purdue Institute of Inflammation and Infectious Diseases, Purdue University, West Lafayette, IN, 47907, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2019.06.089DOI Listing
October 2019

Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.

Cancer Chemother Pharmacol 2019 Jun 9;83(6):1105-1112. Epub 2019 Apr 9.

School of Medicine, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, 22 S. Greene St., Room N9E24, Baltimore, MD, 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-019-03825-2DOI Listing
June 2019

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.

BMC Cancer 2019 May 22;19(1):485. Epub 2019 May 22.

Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-5664-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532223PMC
May 2019

Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in mice.

EBioMedicine 2019 Feb 25;40:231-239. Epub 2019 Jan 25.

Purdue Institute for Drug Discovery, West Lafayette, IN 47907, USA; Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA; Purdue University Center for Cancer Research, Purdue University, West Lafayette, IN 47907, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.01.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413339PMC
February 2019

Dual FLT3/TOPK inhibitor with activity against FLT3-ITD secondary mutations potently inhibits acute myeloid leukemia cell lines.

Future Med Chem 2018 04 13;10(7):823-835. Epub 2018 Feb 13.

Purdue Institute for Drug Discovery, Department of Chemistry, Purdue University Center for Cancer Research, Purdue University, West Lafayette, IN 47907, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/fmc-2017-0298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367750PMC
April 2018

Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4',5'-f][1,3]diazepines.

Bioorg Med Chem 2013 Feb 11;21(3):618-31. Epub 2012 Dec 11.

Laboratory for Drug Design & Synthesis, Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2012.11.050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546142PMC
February 2013